Latest filing published 02 Jul 2025 for EXOZYMES INC., €9,007.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -17.9%Entry US$9.91 · Close at T+365 US$8.14
- +2.4%Entry US$11.33 · Close at T+365 US$11.60
- +21.3%Entry US$13.11 · Close at T+365 US$15.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael Heltzen: trading record in brief
This profile gathers the share dealings of Michael Heltzen in Exozymes Inc. The record holds 4 filings, for trades running from 15 November 2024 to 2 July 2025.
Every open-market trade on record is a purchase: 4 purchases worth €50k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 3 purchases and no sales.
The median purchase comes to €14k. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +22.7%. They describe history only and say nothing certain about the share price ahead.
On 2 July 2025 came the latest disclosure, an open-market purchase for €9,007 in Exozymes Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Heltzen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,040 shares@ US$10.22100.0% of flowCommon StockSEC:0001641172-25-017630:0Canonical exit: 30 Sept 2025 (T+90)
- 1,767 shares@ US$10.7837.2% of flowCommon StockSEC:0001493152-25-002875:1Canonical exit: 17 Apr 2025 (T+90)
- 121 shares@ US$10.725.7% of flowCommon StockSEC:0001493152-25-002875:0Canonical exit: 16 Apr 2025 (T+90)
- 1,984 shares@ US$11.1094.3% of flowCommon StockSEC:0001493152-24-046902:0Canonical exit: 13 Feb 2025 (T+90)
4 of 4 declarations